Abstract
Objectives To examine the characteristics and trends in the industry payments to emergency physicians since the inception of the Open Payments Database in 2013 and the COVID-19 pandemic in 2020.
Methods Using the Open Payments Database between August 2013 and December 2021, this population-based cohort study examined all research and general payments made by the healthcare industry to emergency physicians registered in the National Plan and Provider Enumeration System in the United States. We performed descriptive analyses on payment data and generalized estimating equations for payment trends.
Results Among 50,483 active emergency physicians, 28,678 (56.8%) accepted a total of $457,640,796.73 payments from the healthcare industry between 2013 and 2021. 56.6% and 1.3% of all emergency physicians received general and research payments, respectively. 20.8% ($94.98 millions) of overall industry payments were general payments. Median general and research payments per-physician (interquartile range) were $133.21 ($44.78–$355.77) and $62,842.97 ($10,320.00–$273,285.28), respectively. Top 1% of emergency physicians received 86.2% of overall general payments, respectively. The number of physicians receiving general payments decreased by 2.9% (95% CI: −3.2 to −2.5, p<0.001) annually between 2014 and 2019 and 47.8% (95% CI: −49.8 to −45.6, p<0.001) in 2020. Although there were no significant changes in research payments before COVID-19 pandemic, the research payments significantly increased by 69.4% (95% CI: 28.9–122.7, p<0.001) in 2021 than those in 2020.
Conclusions Majority of emergency physicians accepted general payments from the healthcare industry, but the number of emergency physician accepting the general payments significantly decreased since the inception of Open Payments Database.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding The author received no specific funding for this work.
Conflicts of interest The author declared no conflicts of interest.
Data Availability
All data produced in the present study are available upon reasonable request to the author.
